Beatriz obtained the Degree in Basic and Experimental Biomedicine at the University of Seville in 2016. During these years, she did some interships in different research groups, being specially significant the Gene Expression group at Institute of Biomedicine of Seville (IBiS) where she carried out her Bachelor's Thesis.
After that, she moved to Barcelona in order to complete her education studing a Master Degree in Genetics and Genomics at the University of Barcelona, she performed her Master's thesis in Ageing and Cancer group at The Bellvitge Biomedical Research Institute (IDIBELL).
Beatriz has worked for a year and a half as research assistant in the Molecular Neuroimmunoendocrinology group at Institute of Biomedicine of Seville (IBiS) where she was involving in different projects.
In 2019 Beatriz joined to IBBTEC, she studies the role of cancer associated fibroblasts in the tumour microenvironment in the Tumour Microenvironment group led by Dr. Fernando Calvo.
Cytoskeletal regulators of cancer dissemination. Our team is interested in understanding why and how cancer cells spread through the body. Using state-of-the-art in vitro approaches and pre-clinical models, we study the reciprocal interactions between invading/metastatic cells and their microenvironment, and the molecular rearrangements that promote efficient metastatic behaviours in cancer cells, with a particular emphasis in the modulation of the cytoskeleton.
Mechanisms of stromal reprogramming in cancer. We investigate the environmental cues (chemical or physical) and signals from malignant cells that lead to the emergence of tumour-promoting phenotypes in otherwise normal cells of the tumour microenvironment, with a particular focus in cancer-associated fibroblasts (CAF). Using molecular and bioinformatics tools, we examine patterns of gene expression and signal activation in cancer stroma. We then investigate the effect of reciprocal interactions between cancer cells and normal cells in these patterns, their relevance in tumoural processes and strategies to perturb them to deter tumour progression.
Characterisation of the role of CAF heterogeneity in tumour progression. We have developed in vitro and in vivo systems to investigate CAF behaviour, their contribution to the hallmarks of cancer (e.g. cancer cell growth, invasion, angiogenesis, immune suppression), and the molecular mechanisms controlling them. However, there is molecular and functional heterogeneity within the CAF population, which has a major impact in tumour evolution and therapeutic response. Our team aims at examining this diversity and its contribution to metastatic dissemination and resistance.
Instituto de Biomedicina y Biotecnología de Cantabria.
PCTCAN - Cl. Albert Einstein, 22